Form 4: Entrada Therapeutics Director Sells Shares
Insider Transaction (Form 4)
Kush Parmar, a Director and 10% owner of Entrada Therapeutics, Inc., sold 116,474 shares of common stock on July 30, 2026.
Summary
- Open-market sale: disposed of 114,756 Common Stock at $6.93 ($795,259) on July 30, 2026; holds 2,848,310 after (Indirect).
- Open-market sale: disposed of 1,718 Common Stock at $6.85 ($11,768) on July 31, 2026; holds 2,846,592 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $807,027 of stock on the open market.
Insider Transactions
Kush Parmar — Director, 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-30 | Open-market sale | Common Stock | 114,756 | $7 | $795.3K | 2,848,310 |
| 2026-07-31 | Open-market sale | Common Stock | 1,718 | $7 | $11.8K | 2,846,592 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-30 | Open-market sale (114,756 shares) |
| 2026-07-31 | Open-market sale (1,718 shares) |
Keywords
insider transaction, Form 4, TRDA, Entrada Therapeutics, Inc., bearish, Kush Parmar
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.